HPV vaccine eligible N (%) | HPV vaccine ineligible N (%) | |||||
---|---|---|---|---|---|---|
Agree | Neutral | Disagree | Agree | Neutral | Disagree | |
Vaccinating my children against diseases that can be spread from person to person is important (N = 219) | 114 (99.1) | 0 (0) | 1 (0.9) | 104 (100.0) | 0 (0) | 0 (0) |
It is important for children and adolescents to be vaccinated against HPV (N = 214) | 109 (97.3) | 1 (0.9) | 2 (1.8) | 98 (96.1) | 1 (1.0) | 3 (2.9) |
The HPV vaccine is beneficial for girls between 9 and 13 years old (N = 217) | 107 (93.9) | 1 (0.9) | 6 (5.3) | 97 (94.2) | 2 (1.9) | 4 (3.9) |
The HPV vaccine is safe (N = 215) | 100 (90.1) | 5 (4.5) | 6 (5.4) | 87 (83.7) | 12 (11.5) | 5 (4.8) |
The HPV vaccine is effective in preventing cervical cancer (N = 207) | 98 (90.7) | 4 (3.7) | 6 (5.6) | 95 (96.0) | 3 (3.0) | 1 (1.0) |
The HPV vaccine is beneficial for women over the age of 13 (N = 209) | 90 (83.3) | 1 (0.9) | 17 (15.7) | 84 (83.2) | 5 (4.9) | 12 (11.9) |
Men should be vaccinated against HPV (N = 213) | 85 (74.9) | 3 (2.7) | 24 (21.4) | 85 (84.2) | 3 (3.0) | 13 (12.9) |
The HPV vaccine is beneficial for men (N = 202) | 66 (62.3) | 3 (2.8) | 37 (34.9) | 62 (64.6) | 6 (6.2) | 28 (29.2) |